Search
Search Results
##search.searchResults.foundPlural##
-
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
833PDF: 109HTML: 166 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
772PDF: 894PDF Supp. Files: 81HTML: 215 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1325PDF: 516HTML: 238 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1670PDF: 1024HTML: 1886Untitled: 205Untitled: 189 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2592PDF: 864HTML: 8969Efremov 1: 244Efremov 2: 208 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2872PDF: 1162HTML: 11291 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2640PDF: 892HTML: 17578Fig1 Caligaris: 193Fig.2 Caliga: 236 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1381PDF: 1269HTML: 484 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1440PDF: 839HTML: 3127 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1690PDF: 661HTML: 2440 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1090PDF: 1196Suppl. Files: 576HTML: 94 -
IMMUNOLOGY OF TUBERCULOSIS
5499PDF: 2042HTML: 7346Untitled: 206 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1258PDF: 612HTML: 2886ATRA induced Reactive Hemophagocytosis: A Case Report: 209 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3641PDF: 2556HTML: 1526 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3115PDF: 890HTML: 7219Kost Fig1: 202Kost Fig 2: 191Kost Fig3: 193Kost Fig 4: 205Kost Fig5: 203Kost fig 6: 189 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1816PDF: 589HTML: 320 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1343PDF: 478HTML: 18617Figure 1: 174Figure 2: 156Figure 3: 171Figure 4: 210Figure 5: 182 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1420PDF: 873HTML: 179 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2633PDF: 819HTML: 5289 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2863PDF: 1851HTML: 3703Pellagatti Fig 1: 228Pellagatti Fig. 2: 221 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3308PDF: 1482HTML: 5960Fig1-Ag-Pil: 244Ag-Pil Fig.2: 245 -
-
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2379PDF: 1195HTML: 801 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2389PDF: 1680HTML: 354 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4903PDF: 2900HTML: 2323 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4039PDF: 1071HTML: 3719Untitled: 181Cneo. Fig.1: 117Untitled: 111Untitled: 137Untitled: 143 -
-
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2925PDF: 874HTML: 6560Untitled: 252Untitled: 204Untitled: 226Untitled: 232 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2021PDF: 1024HTML: 736 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3229PDF: 1132HTML: 1821 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1293PDF: 536HTML: 23104 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3160PDF: 932HTML: 2243 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1027PDF: 481HTML: 131 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3279PDF: 796HTML: 2994Figure 1a and 1b: 161Figure 2: 167Figure 3: 188Figure 4: 169Figure 5: 171Tables 1-5: 158







